Loss of function mutations in the LRP5 gene result in osteoporosis-pseudoglioma syndrome (OPPG), a condition characterized by blindness and severe osteoporosis (12, 13). Here, LRP5 is linked to osteoporosis-pseudoglioma syndrome.